GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ToolGen Inc (XKRX:199800) » Definitions » Beneish M-Score

ToolGen (XKRX:199800) Beneish M-Score : -14.00 (As of Dec. 14, 2024)


View and export this data going back to 2014. Start your Free Trial

What is ToolGen Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -14 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for ToolGen's Beneish M-Score or its related term are showing as below:

XKRX:199800' s Beneish M-Score Range Over the Past 10 Years
Min: -14.85   Med: -2.49   Max: 9
Current: -14

During the past 10 years, the highest Beneish M-Score of ToolGen was 9.00. The lowest was -14.85. And the median was -2.49.


ToolGen Beneish M-Score Historical Data

The historical data trend for ToolGen's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ToolGen Beneish M-Score Chart

ToolGen Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3.27 - - -2.49 -7.80

ToolGen Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.05 -7.80 -13.59 -14.85 -14.00

Competitive Comparison of ToolGen's Beneish M-Score

For the Biotechnology subindustry, ToolGen's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ToolGen's Beneish M-Score Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ToolGen's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where ToolGen's Beneish M-Score falls into.



ToolGen Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of ToolGen for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.5539+0.528 * 1.0654+0.404 * 1.0443+0.892 * 0.9954+0.115 * 0.7486
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.4397+4.679 * -0.40423-0.327 * 29.0143
=-14.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Sep24) TTM:Last Year (Sep23) TTM:
Total Receivables was ₩1,998.7 Mil.
Revenue was 441.102 + 159.141 + 121.121 + 277.211 = ₩998.6 Mil.
Gross Profit was 389.362 + 109.615 + 65.104 + 233.789 = ₩797.9 Mil.
Total Current Assets was ₩56,481.4 Mil.
Total Assets was ₩81,775.1 Mil.
Property, Plant and Equipment(Net PPE) was ₩16,697.2 Mil.
Depreciation, Depletion and Amortization(DDA) was ₩1,769.6 Mil.
Selling, General, & Admin. Expense(SGA) was ₩8,375.6 Mil.
Total Current Liabilities was ₩3,105.1 Mil.
Long-Term Debt & Capital Lease Obligation was ₩62,539.0 Mil.
Net Income was -5162.022 + -6179.722 + -4957.007 + -31461.884 = ₩-47,760.6 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = ₩0.0 Mil.
Cash Flow from Operations was -3508.335 + -4426.648 + -3629.147 + -3140.524 = ₩-14,704.7 Mil.
Total Receivables was ₩3,625.1 Mil.
Revenue was 512.724 + 165.433 + 148.041 + 176.943 = ₩1,003.1 Mil.
Gross Profit was 465.146 + 128.638 + 107.391 + 152.75 = ₩853.9 Mil.
Total Current Assets was ₩39,379.9 Mil.
Total Assets was ₩64,598.4 Mil.
Property, Plant and Equipment(Net PPE) was ₩18,715.5 Mil.
Depreciation, Depletion and Amortization(DDA) was ₩1,446.2 Mil.
Selling, General, & Admin. Expense(SGA) was ₩5,844.3 Mil.
Total Current Liabilities was ₩1,774.3 Mil.
Long-Term Debt & Capital Lease Obligation was ₩13.0 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(1998.684 / 998.575) / (3625.078 / 1003.141)
=2.001536 / 3.613727
=0.5539

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(853.925 / 1003.141) / (797.87 / 998.575)
=0.851251 / 0.799009
=1.0654

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (56481.413 + 16697.174) / 81775.079) / (1 - (39379.857 + 18715.488) / 64598.387)
=0.105124 / 0.100669
=1.0443

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=998.575 / 1003.141
=0.9954

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(1446.219 / (1446.219 + 18715.488)) / (1769.587 / (1769.587 + 16697.174))
=0.071731 / 0.095826
=0.7486

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(8375.568 / 998.575) / (5844.302 / 1003.141)
=8.38752 / 5.826003
=1.4397

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((62539.018 + 3105.078) / 81775.079) / ((12.95 + 1774.269) / 64598.387)
=0.80274 / 0.027667
=29.0143

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-47760.635 - 0 - -14704.654) / 81775.079
=-0.40423

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

ToolGen has a M-score of -14.00 suggests that the company is unlikely to be a manipulator.


ToolGen Beneish M-Score Related Terms

Thank you for viewing the detailed overview of ToolGen's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


ToolGen Business Description

Traded in Other Exchanges
N/A
Address
KOR-collar Gasan Digital Valley 1 to 219 digital Byeoksan, 6th 1204 No. ENG No. 1204, Byucksan Digital Valley 6-cha, 219 Gasan Digital 1-ro, Geumcheon-gu, Seoul, KOR
ToolGen Inc is a biotechnology company, which focuses on the development of genome editing technology. Its products include gRNA/Cas9 purified, gRNA/Cas9, and recombinant Cas9 protein, which offers ready-to-use reagents for genome engineering experiments. The company also offers genome-edited cell line; genome-edited mouse/rat; and genome-edited plant services, as well as surrogate reporter synthesis and in-del analysis services.

ToolGen Headlines

No Headlines